ALPHABET'S ISOMORPHIC LABS HAS GRAND AMBITIONS TO ‘SOLVE ALL DISEASES' WITH AI. NOW, IT'S GEARING UP FOR ITS FIRST HUMAN TRIALS

Summary from the TLDR newsletter

Isomorphic Labs, Alphabet's secretive drug discovery arm, is preparing to launch human trials of AI-designed drugs. The company was born from one of DeepMind's most celebrated breakthroughs, AlphaFold, an AI system capable of predicting protein structures and interactions with a high level of accuracy. The system has helped researchers design medicines faster and more precisely.